Ayman Shehata Dawood
Tanta, Algharbia, 31111, Egypt
NCT Number: NCT03580031
This study will be conducted to assess the effect of booster dose of hCG on the unruptured follicles in non IVF/ICSI cycles.
Looking for future studies?
Notify Me20 year–40 year
Female
Interventional
Phase 4
Tanta, Algharbia, 31111, Egypt
In this study enrolled patients (n=160) who underwent controlled ovarian stimulation and timed intercourse with unruptured mature graffian follicle 48 hours after IM 10,000 IU HCG dose. Patients were allocated randomly into intervention group and control group. In the intervention group another booster dose (10,000 IU of hCG) was given IM while in the control group 2 ml normal saline was given IM leaving follicles for spontaneous rupture
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A booster dose (10,000 IU of hCG) was given IM 48 hours after first triggering dose
2 ml of normal saline will be injected 48 hours after first triggering dose
Time frame: 48 hours
rupture of dominant follicle manifested by disappearance of follicle and presence of free fluid in douglas pouch
Time frame: 15 days
Number of cases with positive serum pregnancy test
Tanta University
Other
Booster Dose of Human Chorionic Gonadotrophin for Unruptured Follicle in Non IVF/ICSI Cycles: A Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.